Histological and biological evolution of human premalignant breast disease.
about
PI-3 kinase activity is necessary for ERK1/2-induced disruption of mammary epithelial architecture.Deregulation of scribble promotes mammary tumorigenesis and reveals a role for cell polarity in carcinomaThe role of oestrogen and progesterone receptors in human mammary development and tumorigenesisExpression of AMAP1, an ArfGAP, provides novel targets to inhibit breast cancer invasive activitiesEvidence that molecular changes in cells occur before morphological alterations during the progression of breast ductal carcinomaThe origins of estrogen receptor alpha-positive and estrogen receptor alpha-negative human breast cancer.A new model for ductal carcinoma in situ suggests strategies for treatmentMammographic density is related to stroma and stromal proteoglycan expressionThe diagnosis and management of pre-invasive breast disease: flat epithelial atypia--classification, pathologic features and clinical significanceEndocrinology and hormone therapy in breast cancer: new insight into estrogen receptor-alpha function and its implication for endocrine therapy resistance in breast cancerDuctal carcinoma in situ: terminology, classification, and natural historyAromatase expression in atypical ductal hyperplasia in women.Atypical hyperplasia of the breast--risk assessment and management options.Gene expression profiles of human breast cancer progression.Global gene expression profiling: a complement to conventional histopathologic analysis of neoplasia.Gene expression profiling of the tumor microenvironment during breast cancer progression.High prevalence of PIK3CA/AKT pathway mutations in papillary neoplasms of the breast.Keratin 18 attenuates estrogen receptor alpha-mediated signaling by sequestering LRP16 in cytoplasmMinireview: Progesterone Regulation of Proliferation in the Normal Human Breast and in Breast Cancer: A Tale of Two Scenarios?Biomarkers expression in benign breast diseases and risk of subsequent breast cancer: a case-control studyEvaluating the response of neoadjuvant chemotherapy for treatment of breast cancer: are tumor biomarkers and dynamic contrast enhanced MR images useful predictive tools?Presence of an in situ component is associated with reduced biological aggressiveness of size-matched invasive breast cancer.Vasohibin‑2 promotes proliferation in human breast cancer cells via upregulation of fibroblast growth factor‑2 and growth/differentiation factor‑15 expressionKi67: a time-varying biomarker of risk of breast cancer in atypical hyperplasiaPattern response of dendritic cells in the tumor microenvironment and breast cancerStage of breast cancer progression influences cellular response to activation of the WNT/planar cell polarity pathwayMicroenvironmental influences that drive progression from benign breast disease to invasive breast cancer.Functional interrogation of breast cancer: from models to drugs.Estrogen receptor expression in atypical hyperplasia: lack of association with breast cancer.Altered AIB1 or AIB1Δ3 expression impacts ERα effects on mammary gland stromal and epithelial contentMolecular markers and therapeutic targets in ductal carcinoma in situ.Breast cancer risk after diagnosis by screening mammography of nonproliferative or proliferative benign breast disease: a study from a population-based screening program.Mechanisms of Gefitinib-mediated reversal of tamoxifen resistance in MCF-7 breast cancer cells by inducing ERα re-expression.Vav2 protein overexpression marks and may predict the aggressive subtype of ductal carcinoma in situp16(INK4a) expression and breast cancer risk in women with atypical hyperplasia.High-throughput genomic technology in research and clinical management of breast cancer. Molecular signatures of progression from benign epithelium to metastatic breast cancer.Classification of ductal carcinoma in situ by gene expression profiling.New insights into estrogen receptor function in human breast cancer.YB-1 drives preneoplastic progression: Insight into opportunities for cancer preventionGenes involved in breast cancer progression: analysis of global changes in gene expression or retroviral tagging?
P2860
Q22000770-56AD4DF5-37C3-455B-93AF-A2F243F18620Q24319145-2D0A1D43-CCF4-424E-8EDF-D09A40C5C532Q24542480-1DBF25C9-747E-49D6-AE77-A85CDB989D54Q24555819-845C7CC2-D20A-4DDF-BA25-0E4D294A5217Q24653361-17D88CCD-C816-45F6-8E3A-635349725A89Q24796156-CD346E64-A72D-484A-AF44-760C1F1F8565Q24802734-85C5D363-99F5-4990-896B-794029669E2DQ24803332-14EBEDDF-9138-4104-B950-F0CF34BED776Q24803422-20D1630D-FD9C-4310-B543-958DDBD93613Q24813627-F67C7D1F-50CB-41A9-955B-412ACA7703A3Q28296046-7EF985DB-8256-4D3F-A3B8-259AAD69BB26Q30252881-2F61EEB9-41B4-4FA6-AC48-5102336187EAQ30301033-16EAE488-9080-4B7A-9B0A-A5FE24084A78Q33186821-6201DD23-8A0A-49D1-B650-6F0DD68F31BBQ33227605-9453B9FE-5A99-41D9-A7CF-B32879816A49Q33404889-6ADA8CF0-86DF-457C-A333-61D48255B024Q33515565-F369E02E-1D38-4832-BFF9-B7E8605878D7Q33520827-DA6ADAEA-E23D-40D5-94BB-8403FDDE38A5Q33631557-034BE3AB-A376-4B50-9C20-ACA17D702441Q33775354-CA61F826-76E0-470C-A9CD-2CE741529B7DQ33814616-0824774F-D489-441A-B6E7-CC993D1046BDQ33834430-27DF758B-B7D1-4E9B-B5F8-E936F0DBE97FQ33891210-509408D9-944C-4F86-B93E-651CE3DF4031Q33932379-CC5083B6-E7A7-4801-BD28-9AF8B32506B8Q34023724-29823A70-364D-4796-95CA-28D5673FDC11Q34157590-B96B0E96-A08E-41E4-A069-8BBD2F07506EQ34444593-1E07E6D7-A9C5-4093-ACE8-3BA815A03A17Q34626308-B2855A6D-AE0E-4BD9-902F-0CA3D31B7DE5Q34629839-1CFA8977-00AA-4794-ABB5-842402F8A7FBQ34712100-5EDE060F-E481-49A2-B103-EFFCA504271EQ34872645-0093968E-757B-49F8-93AC-C0792E573336Q34983619-5E24D007-B4DD-48A6-817C-E86CF5ECA74AQ35040890-A6E5A9BD-EEDD-43C4-8086-5C9E14208F16Q35184951-9F0BC6BD-5603-420E-89FA-E110B3613D3AQ35597120-F43AB904-3CCA-4FEF-BF20-6AD6D16FEAF8Q35605800-E16BD763-86F5-41AD-82E0-ECBDA1BE4CB5Q35605885-B1AD645D-853F-46C9-9308-E7118CE30834Q35622050-786521DC-EC13-4B20-A9D3-8A396BE4C84BQ35640233-892AAE02-A0D3-4F54-A625-9FE5BC75308BQ35748167-CC49AE2A-AAC9-4AF4-96A0-2AC7B71A1077
P2860
Histological and biological evolution of human premalignant breast disease.
description
2001 nî lūn-bûn
@nan
2001 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի մարտին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Histological and biological evolution of human premalignant breast disease.
@ast
Histological and biological evolution of human premalignant breast disease.
@en
Histological and biological evolution of human premalignant breast disease.
@nl
type
label
Histological and biological evolution of human premalignant breast disease.
@ast
Histological and biological evolution of human premalignant breast disease.
@en
Histological and biological evolution of human premalignant breast disease.
@nl
prefLabel
Histological and biological evolution of human premalignant breast disease.
@ast
Histological and biological evolution of human premalignant breast disease.
@en
Histological and biological evolution of human premalignant breast disease.
@nl
P2093
P356
P1476
Histological and biological evolution of human premalignant breast disease.
@en
P2093
P356
10.1677/ERC.0.0080047
P577
2001-03-01T00:00:00Z